Microvascular MRI and unsupervised clustering yields histology-resembling images in two rat models of glioma

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 8, 2014, Pages 1354-1362

  Coquery, Nicolas ^a,b   Francois, Olivier ^b,c   Lemasson, Benjamin ^a,b   Debacker, Clément ^a,b,d   Farion, Régine ^a,b   Rémy, Chantal ^a,b   Barbier, Emmanuel Luc ^a,b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c LABORATOIRE TIMC IMAG   (France)

^d Bruker Corporation   (United States)

Author keywords

brain; glioma; MRI perfusion; pattern recognition; radiomics; unsupervised clustering

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ERYTHROSINE; HEMATOXYLIN; PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CELL DENSITY; CEREBRAL METABOLIC RATE OF OXYGEN; CLUSTER ANALYSIS; CONTROLLED STUDY; DIFFUSION COEFFICIENT; ECHO PLANAR IMAGING; GLIOMA; HISTOPATHOLOGY; HYPOXIA; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; METASTASIS; MICROVASCULARIZATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OXYGEN SATURATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TUMOR VOLUME;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DISCRIMINANT ANALYSIS; GLIOMA; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; RATS, WISTAR;

EID: 84905498473     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.90     Document Type: Article

References (43)

1. Preul MC, Caramanos Z, Leblanc R, Villemure JG, Arnold DL. Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors. NMR Biomed 1998; 11: 192-200.
2. Lin G-C, Wang W-J, Wang C-M, Sun S-Y. Automated classification of multi-spectral MR images using linear discriminant analysis. Comput Med Imaging Graph 2010; 34: 251-268.
3. Li Y, Sima DM, Van Cauter S, Himmelreich U, Sava ARC, Pi Y et al. Unsupervised nosologic imaging for glioma diagnosis. IEEE Trans Biomed Eng 2013; 60: 1760-1763.
4. Barbier EL, Lamalle L, Décorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13: 496-520.
5. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen J-F et al. Vessel size imaging. Magn Reson Med 2001; 45: 397-408.
6. He X, Yablonskiy DA. Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med 2007; 57: 115-126.
7. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
8. Krainik A, Hund-Georgiadis M, Zysset S, von Cramon DY. Regional impairment of cerebrovascular reactivity and BOLD signal in adults after stroke. Stroke 2005; 36: 1146-1152.
9. Dominietto M, Rudin M. Could magnetic resonance provide in vivo histology? Front Syst Biol 2014; 4: 298.
10. De Edelenyi FS, Rubin C, Estève F, Grand S, Décorps M, Lefournier V et al. A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med 2000; 6: 1287-1289.
11. Devos A, Simonetti AW, van der Graaf M, Lukas L, Suykens JAK, Vanhamme L et al. The use of multivariate MR imaging intensities versus metabolic data from MR spectroscopic imaging for brain tumour classification. J Magn Reson 2005; 173: 218-228.
12. MacQueen JB. Some Methods for Classification and Analysis of MultiVariate Observations. In: Cam LML, Neyman J (eds). Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. University of California Press, 1967, pp 281-297.
13. Mouthuy N, Cosnard G, Abarca-Quinones J, Michoux N. Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases. J Neuroradiol 2012; 39: 301-307.
14. Fraley C, Raftery AE. Model-based clustering, discriminant analysis, and density estimation. J Am Stat Assoc 2002; 97: 611-631.
15. Coquery N, Pannetier N, Farion R, Herbette A, Azurmendi L, Clarencon D et al. Distribution and radiosensitizing effect of cholesterol-coupled dbait molecule in rat model of glioblastoma. PLoS One 2012; 7: e40567.
16. Lyng H, Sundfør K, Rofstad EK. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol 1997; 44: 163-169.
17. Christen T, Lemasson B, Pannetier N, Farion R, Segebarth C, Rémy C et al. Evaluation of a quantitative blood oxygenation level-dependent (qBOLD) approach to map local blood oxygen saturation. NMR Biomed 2011; 24: 393-403.
18. Lemasson B, Christen T, Tizon X, Farion R, Fondraz N, Provent P et al. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and antiangiogenic drug effects. NMR Biomed 2011; 24: 473-482.
19. Lemasson B, Christen T, Serduc R, Maisin C, Bouchet A, Le Duc G et al. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model. Radiology 2012; 265: 743-752.
20. Troprès I, Lamalle L, Péoc'h M, Farion R, Usson Y, Décorps M et al. In vivo assessment of tumoral angiogenesis. Magn Reson Med 2004; 51: 533-541.
21. Lemasson B, Serduc R, Maisin C, Bouchet A, Coquery N, Robert P et al. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media. Radiology 2010; 257: 342-352.
22. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996; 16: 1236-1249.
23. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998; 40: 383-396.
24. Trembath D, Miller CR, Perry A. Gray zones in brain tumor classification: evolving concepts. Adv Anat Pathol 2008; 15: 287-297.
25. Cha S. Neuroimaging in neuro-oncology. Neurotherapeutics 2009; 6: 465-477.
26. Galbán CJ, Chenevert TL, Meyer CR, Tsien C, Lawrence TS, Hamstra DA et al. The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 2009; 15: 572-576.
27. Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 2005; 102: 16759-16764.
28. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
29. Emblem KE, Nedregaard B, Nome T, Due-Tonnessen P, Hald JK, Scheie D et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008; 247: 808-817.
30. Moisan A, Pannetier N, Grillon E, Richard M-J, de Fraipont F, Rémy C et al. Intracerebral injection of human mesenchymal stem cells impacts cerebral microvasculature after experimental stroke: MRI study. NMR Biomed 2012; 25: 1340-1348.
31. Boehm-Sturm P, Farr TD, Adamczak J, Jikeli JF, Mengler L, Wiedermann D et al. Vascular changes after stroke in the rat: a longitudinal study using optimized magnetic resonance imaging. Contrast Media Mol Imaging 2013; 8: 383-392.
32. Biron KE, Dickstein DL, Gopaul R, Jefferies WA. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 2011; 6: e23789.
33. Marchi N, Lerner-Natoli M. Cerebrovascular remodeling and epilepsy. Neuroscientist 2012; 19: 304-312.
34. Zacharaki EI, Wang S, Chawla S, Soo Yoo D, Wolf R, Melhem ER et al. Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. Magn Reson Med 2009; 62: 1609-1618.
35. Zacharaki EI, Kanas VG, Davatzikos C. Investigating machine learning techniques for MRI-based classification of brain neoplasms. Int J Comput Assist Radiol Surg 2011; 6: 821-828.
36. Zö llner FG, Emblem KE, Schad LR. SVM-based glioma grading: optimization by feature reduction analysis. Z Für Med Phys 2012; 22: 205-214.
37. Jacobs VL, Valdes PA, Hickey WF, De Leo JA. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro 2011; 3: 171-181.
38. Valable S, Lemasson B, Farion R, Beaumont M, Segebarth C, Remy C et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 2008; 21: 1043-1056.
39. Boś A, Bergmann R, Strobel K, Hofheinz F, Steinbach J, van den Hoff J. Cerebral blood flow quantification in the rat: a direct comparison of arterial spin labeling MRI with radioactive microsphere PET. EJNMMI Res 2012; 2: 47.
40. Paudyal R, Ewing JR, Nagaraja TN, Bagher-Ebadian H, Knight RA, Panda S et al. The concordance of MRI and quantitative autoradiography estimates of the transvascular transfer rate constant of albumin in a rat brain tumor model. Magn Reson Med 2011; 66: 1422-1431.
41. Chung C, Jalali S, Foltz W, Burrell K, Wildgoose P, Lindsay P et al. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy. Int J Radiat Oncol 2013; 85: 805-812.
42. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in Oncology. J Clin Oncol 2007; 25: 4104-4109.
43. Thorsen F, Jirak D, Wang J, Sykova E, Bjerkvig R, Enger PØ et al. Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics. NMR Biomed 2008; 21: 830-838.